Entrepreneurial seasoned executive, strategic leader across all stages of product development, licensure and commercialization. Therapeutic focus for over 20 years in oncology (immune therapeutics, biologics), hematology, infectious diseases, inflammatory disorders, autoimmune disorders, vaccines, gastroenterology, cell and gene therapies. Rare genetic disorders. We are Asklepion Pharmaceuticals, LLC., a biopharmaceutical company based in Baltimore, Maryland. In 2006, the need for drug research and development for both large patient populations and very small subsets of patients became the catalyst for creating this company. We have entered into partnerships with universities, other pharmaceutical companies, drug distributors, and financial assistance programs to build a firm foundation for products to be approved by the FDA and commercialized.
Share This Speaker